| 1. |
Miller, A. D., Miller, D. G., Garcia, J. V., and Lynch, C. M. (1993) Use of retroviral vectors for gene transfer and expression.
Methods Enzymol.
217, 581–599.
|
| |
| 2. |
Cone, R. D. and Mulligan, R. C. (1984) High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant
retrovirus with broad mammalian host range. Proc. Natl. Acad. Sci. USA
81, 6349–6353.
|
| |
| 3. |
Hock, R. A. and Miller, A. D. (1986) Retrovirus-mediated transfer and expression of drug resistance genes in human haematopoietic
progenitor cells. Nature
320, 275–277.
|
| |
| 4. |
Miller, A. D., Eckner, R. J., Jolly, D. J., Friedmann, T., and Verma, I. M. (1984) Expression of a retrovirus encoding human
HPRT in mice. Science
225, 630–632.
|
| |
| 5. |
Miller, A. D., Law, M. F., and Verma, I. M. (1985) Generation of helper-free amphotropic retroviruses that transduce a dominant-acting,
methotrexate-resistant dihydrofolate reductase gene. Mol. Cell Biol.
5, 431–437.
|
| |
| 6. |
Miller, A. D., Ong, E. S., Rosenfeld, M. G., Verma, I. M., and Evans, R. M. (1984) Infectious and selectable retrovirus containing
an inducible rat growth hormone minigene. Science
225, 993–998.
|
| |
| 7. |
Stuhlmann, H., Cone, R., Mulligan, R. C., and Jaenisch, R. (1984) Introduction of a selectable gene into different animal
tissue by a retrovirus recombinant vector. Proc. Natl. Acad. Sci. USA
81, 7151–7155.
|
| |
| 8. |
Williams, D. A., Lemischka, I. R., Nathan, D. G., and Mulligan, R. C. (1984) Introduction of new genetic material into pluripotent
haematopoietic stem cells of the mouse. Nature
310, 476–480.
|
| |
| 9. |
Allay, J. A., Persons, D. A., Galipeau, J., et al. (1998) In vivo selection of retrovirally transduced hematopoietic stem
cells. Nat. Med.
4, 1136–1143.
|
| |
| 10. |
Allay, J. A., Spencer, H. T., Wilkinson, S. L., Belt, J. A., Blakley, R. L., and Sorrentino, B. P. (1997) Sensitization of
hematopoietic stem and progenitor cells to trimetrexate using nucleoside transport inhibitors. Blood
90, 3546–3554.
|
| |
| 11. |
Corey, C. A., DeSilva, A. D., Holland, C. A., and Williams, D. A. (1990) Serial transplantation of methotrexate-resistant
bone marrow: protection of murine recipients from drug toxicity by progeny of transduced stem cells. Blood
75, 337–343.
|
| |
| 12. |
Evans, J. T., Cravens, P., Gatlin, J., Kelly, P. F., Lipsky, P. E., and Garcia, J. V. (2001) Pre-clinical evaluation of an
in vitro selection protocol for the enrichment of transduced CD34+ cell-derived human dendritic cells. Gene Ther.
8, 1427–1435.
|
| |
| 13. |
Gatlin, J., Douglas, J., Evans, J. T., Collins, R. H., Wendel, G. D., and Garcia, J. V. (2000) In vitro selection of lentivirus
vector-transduced human CD34+ cells (In Process Citation). Hum. Gene Ther.
11, 1949–1957.
|
| |
| 14. |
Lewis, W. S., Cody, V., Galitsky, N., et al. (1995) Methotrexate-resistant variants of human dihydrofolate reductase with
substitutions of leucine 22. Kinetics, crystallography, and potential as selectable markers. J. Biol. Chem.
270, 5057–5064.
|
| |
| 15. |
Spencer, H. T., Sleep, S. E., Rehg, J. E., Blakley, R. L., and Sorrentino, B. P. (1996) A gene transfer strategy for making
bone marrow cells resistant to trimetrexate. Blood
87, 2579–2587.
|
| |
| 16. |
Blau, C. A., Neff, T., and Papayannopoulou, T. (1997) Cytokine prestimulation as a gene therapy strategy: implications for
using the MDR1 gene as a dominant selectable marker. Blood
89, 146–154.
|
| |
| 17. |
Schiedlmeier, B., Kuhlcke, K., Eckert, H. G., Baum, C., Zeller, W. J., and Fruehauf, S. (2000) Quantitative assessment of
retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted
in nonobese diabetic/severe combined immunodeficient mice. Blood
95, 1237–1248.
|
| |
| 18. |
Sorrentino, B. P., Brandt, S. J., Bodine, D., et al. (1992) Selection of drug-resistant bone marrow cells in vivo after retroviral
transfer of human MDR1. Science
257, 99–103.
|
| |
| 19. |
Allay, J. A., Davis, B. M., and Gerson, S. L. (1997) Human alkyltransferase-transduced murine myeloid progenitors are enriched
in vivo by BCNU treatment of transplanted mice. Exp. Hematol.
25, 1069–1076.
|
| |
| 20. |
Davis, B. M., Reese, J. S., Koc, O. N., Lee, K., Schupp, J. E., and Gerson, S. L. (1997) Selection for G156A O6-methylguanine
DNA methyltransferase gene-transduced hematopoietic progenitors and protection from lethality in mice treated with O6-benzylguanine
and 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res.
57, 5093–5099.
|
| |
| 21. |
Maze, R., Kapur, R., Kelley, M. R., Hansen, W. K., Oh, S. Y., and Williams, D. A. (1997) Reversal of 1,3-bis(2-chloroethyl)-1-nitrosourea-induced
severe immunodeficiency by transduction of murine long-lived hemopoietic progenitor cells using O6-methylguanine DNA methyltransferase
complementary DNA. J. Immunol.
158, 1006–1013.
|
| |
| 22. |
Douglas, J., Kelly, P., Evans, J. T., and Garcia, J. V. (1999) Efficient transduction of human lymphocytes and CD34+ cells
via human immunodeficiency virus-based gene transfer vectors. Hum. Gene Ther.
10, 935–945.
|
| |
| 23. |
Evans, J. T., Kelly, P. F., O’Neill, E., and Garcia, J. V. (1999) Human cord blood CD34+CD38− cell transduction via lentivirus-based gene transfer vectors. Hum. Gene Ther.
10, 1479–1489.
|
| |
| 24. |
Gatlin, J., Melkus, M. W., Padgett, A., Kelly, P. F., and Garcia, J. V. (2001) Engraftment of NOD/SCID mice with human CD34(+)
cells transduced by concentrated oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114)
envelope protein. J. Virol.
75, 9995–9999.
|
| |
| 25. |
Gatlin, J., Padgett, A., Melkus, M. W., Kelly, P. F., and Garcia, J. V. (2001). Long-term engraftment of nonobese diabetic/severe
combined immunodeficient mice with human CD34+ cells transduced by a self-inactivating human immunodeficiency virus type 1
vector. Hum. Gene Ther.
12(9), 1079–1089.
|
| |
| 26. |
Naldini, L., Blomer, U., Gage, F. H., Trono, D., and Verma, I. M. (1996) Efficient transfer, integration, and sustained long-term
expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA
93, 11,382–11,388.
|
| |
| 27. |
Naldini, L., Blomer, U., Gallay, P., et al. (1996) In vivo gene delivery and stable transduction of nondividing cells by a
lentiviral vector. Science
272, 263–267.
|
| |
| 28. |
Ranga, U., Woffendin, C., Yang, Z. Y., et al. (1997) Cell and viral regulatory elements enhance the expression and function
of a human immunodeficiency virus inhibitory gene. J. Virol.
71, 7020–7029.
|
| |
| 29. |
Granelli-Piperno, A., Zhong, L., Haslett, P., Jacobson, J., and Steinman, R. M. (2000) Dendritic cells, infected with vesicular
stomatitis virus-pseudotyped HIV-1, present viral antigens to CD4+ and CD8+ T cells from HIV-1-infected individuals. J. Immunol.
165, 6620–6626.
|
| |
| 30. |
Li, X., Mukai, T., Young, D., Frankel, S., Law, P., and Wong-Staal, F. (1998) Transduction of CD34+ cells by a vesicular stomach
virus protein G (VSV-G) pseudotyped HIV-1 vector. Stable gene expression in progeny cells, including dendritic cells. J. Hum. Virol.
1, 346–352.
|
| |
| 31. |
Belt, J. A., Marina, N. M., Phelps, D. A., and Crawford, C. R. (1993) Nucleoside transport in normal and neoplastic cells.
Adv. Enzyme Regul.
33, 235–252.
|
| |
| 32. |
Lynch, T. P., Paran, J. H., and Paterson, A. R. (1981) Therapy of mouse leukemia L1210 with combinations of nebularine and
nitrobenzylthioinosine 5′-monophosphate. Cancer Res.
41, 560–565.
|
| |
| 33. |
Rongen, G. A., Smits, P., Ver Donck, K., et al. (1995) Hemodynamic and neurohumoral effects of various grades of selective
adenosine transport inhibition in humans. Implications for its future role in cardioprotection. J. Clin. Invest.
95, 658–668.
|
| |